Logo Eur-Intafar, logo Intafar
Communauté EuropéenneULgFp6CIP

About Us

Eur-Intafar Project

Welcome to the home page of the EUR-INTAFAR project!

EUR-INTAFAR is the acronym for Inhibition of New TArgets for Fighting Antibiotic Resistance. This project aims at a better understanding of the physiology and biochemistry of bacterial cell morphogenesis and peptidoglycan biosynthesis. On this basis, compounds will be designed to interfere with these processes and the active compounds will be developed as leads in the discovery of new antibacterial agents directed against new targets.

EUR-INTAFAR is an Integrated Project (IP) funded under the ‘Life Sciences, Genomics and Biotechnology for Health (LifeSciHealth)’ section of the European Community Sixth Framework Programme (FP6). The Centre for Protein Engineering at the University of Liège (Belgium) led by Professor Jean-Marie Frère, is the coordinator of this project.

EUR-INTAFAR assembles a critical mass of scientists (17 partners from 6 European countries) who are recognized in their fields. Indeed, many of the partners are presently considered as world leaders in the proposed study areas. This project involves large laboratories, several smaller ones and two SME. This cross-border research network will create a unique opportunity to generate knowledge and to stimulate technical innovation, transfer of technology and know-how.

The project is financed by the European Commission under The Sixth Research Framework Programme and coordinated by the University of Liege through The Center for Protein Engineering.